Completed NA INTERVENTIONAL 2-arm NCT02178501

Omega-3 Fatty Acids Supplementation and Atherothrombotic Biomarkers in Type 2 Diabetes and Cardiovascular Disease.

The Effect of Omega-3 Polyunsaturated Acids Supplementation on Endothelial Function, Oxidative Stress, Platelet Aggregation, Blood Coagulation and Inflammation in Patients With Type 2 Diabetes and Cardiovascular Disease

Sponsor: Jagiellonian University

Conditions Cardiovascular Diseases Type 2 Diabetes

Interventions Omega-3 PUFA

Updated 5 times since 2017 Last updated: Nov 27, 2016 Started: Jan 31, 2013 Primary completion: Dec 31, 2015 Completion: Feb 29, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Cardiovascular Diseases and Type 2 Diabetes and is currently completed. Jagiellonian University leads this study, which shows 5 recorded versions since 2013 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jan 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Jagiellonian University
National Science Centre, Poland

Data source: Jagiellonian University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Katowice, Poland
• Krakow, Poland